India's Strides Pharma Science up on unit getting FDA approval

Strides Pharma Science

23/11/2023 08:45

** Shares of pharmaceutical company Strides Pharma Science
 SRID.NS  rise as much as 3.1% to 502 rupees
    ** SRID says its unit got U.S. FDA approval for Generic
Suprep Bowel Prep Kit - oral solution of sodium sulphate,
potassium sulphate and magnesium sulphate oral solution
    ** Stock up 41.8% YTD, including day's gains, last up ~2%


 (Reporting by Anisha Ajith in Bengaluru)
 ((anisha.ajith@thomsonreuters.com))